Study Stopped
Low enrollment
Effect of Holofiber Socks and Bedding on Pain and Quality of Sleep in Subjects With Chronic Foot Pain
1 other identifier
interventional
60
1 country
1
Brief Summary
This study is designed to assess the effects of socks and bedding materials on foot pain, the level of blood oxygen existing in the feet and quality of sleep in subjects who have chronic foot pain from either diabetic neuropathy or other conditions, e.g., peripheral arterial disease, regenerative joint disease). The three main hypotheses to be tested are: 1)compared to placebo socks, subjects wearing Holofiber socks experience reduction in foot pain, 2)compared to placebo bedding, subjects sleeping in beds lined with a Holofiber mattress pad experience improved quality of sleep and 3) compared to placebo socks, subjects who wear Holofiber socks will have increased blood oxygenation levels in their feet.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2007
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2007
CompletedFirst Submitted
Initial submission to the registry
April 9, 2007
CompletedFirst Posted
Study publicly available on registry
April 11, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2009
CompletedJune 4, 2010
June 1, 2010
2.7 years
April 9, 2007
June 2, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Significant differences between the average scores from the two pre-randomization questionnaire sets and the two post-randomization questionnaire sets.
four weeks
Oxygenation levels of blood in the feet will be compared between Holofiber and placebo socks at several time points using standard nonparametric t-test statistics.
Baseline photos of feet without socks; immediately afer baseline photos, Holofiber sock placed on one foot, placebo sock placed on the other foot; second photos with socks one hour later; final photos with socks four hours later
Study Arms (2)
1
EXPERIMENTALSubjects will be given 3 pairs of socks (subjects with foot pain only) and bedding (mattress pad)fabricated from 1.8 dernier polyethylene terephthalate (PET) fabric to which Holofiber particles have been added during fiber manufacture.
2
PLACEBO COMPARATORSubjects will be given 3 pairs of socks (subjects with foot pain only) and bedding (mattress pad)fabricated from 1.8 dernier polyethylene terephthalate (PET) fabric.
Interventions
Subjects will be given 3 pairs of socks (subjects with foot pain only) and bedding (mattress pad)fabricated from 1.8 dernier polyethylene terephthalate (PET) fabric to which Holofiber particles have been added during fiber manufacture.
Subjects will be given 3 pairs of socks (subjects with foot pain only) and bedding (mattress pad)fabricated from 1.8 dernier polyethylene terephthalate (PET)fabric.
Eligibility Criteria
You may qualify if:
- Presence of diabetic neuropathic pain with score of 3 or higher on the McGill Short Form Pain Survey
- Presence of sensory neuropathy with monofilament (Semmes-Weinstein) testing, as defined as failure to sense the filament in 2 locations (out of six total) on a least one foot.
- Previous diagnosis of diabetes (type II) as well as diabetic neuropathy by a physician
- Age greater or equal to 21
You may not qualify if:
- Presence of significant peripheral arterial disease in either lower extremity (abi greater than 0.9 bilaterally)
- Skin ulceration on either foot or limb threat from infection or vascular disease at study enrollment
- Inability to comply with study procedures or give informed consent
- Women of child bearing potential
- Spouse/partner is a women of child bearing potential and you share the same bed
- Non-ambulatory status
- Inability to comply with study restrictions on changing sleeping or pain medication
- Severe psychiatric or medical disorder that would affect compliance
- Known allergy to PET or Dacron
- Chronic foot or angle pain with a score of 3 or higher on the McGill Short Form Pain Scale
- Absence of sensory neuropathy with monofilament (Semmes-Weinstein) testing, as defined as ability to sense the filament in 6 locations (out of 6 total) on both feet
- The presence of a condition that causes chronic foot pain such as arthritis, peripheral arterial disease, plantar fasciitis, or other conditions not related to diabetic neuropathy, previously diagnosed by a health care provider
- Age greater to or equal to 21
- Presence of significant peripheral arterial disease in either lower extremity (abi less than or equal to 0.5 in either extremity)
- Skin ulceration on either foot or limb threat from infection or vascular disease at study enrollment
- +8 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
VA Long Beach Healthcare System
Long Beach, California, 90822, United States
Related Publications (1)
York RM, Gordon IL. Effect of optically modified polyethylene terephthalate fiber socks on chronic foot pain. BMC Complement Altern Med. 2009 Apr 22;9:10. doi: 10.1186/1472-6882-9-10.
PMID: 19386127DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ian Gordon, M.D., Ph.D.
VA Long Beach Healthcare System
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
April 9, 2007
First Posted
April 11, 2007
Study Start
April 1, 2007
Primary Completion
December 1, 2009
Study Completion
December 1, 2009
Last Updated
June 4, 2010
Record last verified: 2010-06